APA

Liang X., Briaux A., Becette V., Benoist C., Boulai A., Chemlali W., Schnitzler A., Baulande S., Rivera S., Mouret-Reynier M., Bouvet L. V., De La Motte Rouge T., Lemonnier J., Lerebours F. & Callens C. (20200109). Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609). : Journal of hematology & oncology.

Chicago

Liang Xu, Briaux Adrien, Becette Véronique, Benoist Camille, Boulai Anais, Chemlali Walid, Schnitzler Anne, Baulande Sylvain, Rivera Sofia, Mouret-Reynier Marie-Ange, Bouvet Laurence Venat, De La Motte Rouge Thibaut, Lemonnier Jérôme, Lerebours Florence and Callens Céline. 20200109. Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609). : Journal of hematology & oncology.

Harvard

Liang X., Briaux A., Becette V., Benoist C., Boulai A., Chemlali W., Schnitzler A., Baulande S., Rivera S., Mouret-Reynier M., Bouvet L. V., De La Motte Rouge T., Lemonnier J., Lerebours F. and Callens C. (20200109). Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609). : Journal of hematology & oncology.

MLA

Liang Xu, Briaux Adrien, Becette Véronique, Benoist Camille, Boulai Anais, Chemlali Walid, Schnitzler Anne, Baulande Sylvain, Rivera Sofia, Mouret-Reynier Marie-Ange, Bouvet Laurence Venat, De La Motte Rouge Thibaut, Lemonnier Jérôme, Lerebours Florence and Callens Céline. Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609). : Journal of hematology & oncology. 20200109.